A Center for Point of Care Technologies for Nutrition, Infection and Cancer
Educational Resources
The Global Health Point-of-Care Diagnostics Accelerator builds on the expertise within the L2M network and focuses on the development of go-to-market strategies for the PORTENT cohort. See our video resources below.
2024-25 PORTENT Global Health Point-of-Care Diagnostics Accelerator Program
Overview of PORTENT L2M Workshops PORTENT Team, November 12, 2024.
Path-to-Market in LMIC for POCD 2025 Lara Vojnov, PhD, The Global Health Impact Group, Chief Scientist, December 3, 2024.
Regulatory Strategy in LMIC Robyn Meurant, ACT-IVD Principal Consultant, March 18, 2025.
2023-24 PORTENT Global Health Point-of-Care Diagnostics Accelerator Program
The Role of Intellectual Property for Life Science Companies in Low and Mid-Resourced Markets Philip Braginski, JD, Tartar, Krinsky & Drogin, Partner, Co-Chair of Life Sciences and China & India Practice, May 15, 2024.
Needs Assessment – an essential step in developing, validating and scaling up of POCT: Why & What Nitika Pai, PhD and Varun Mohan, MBA, McGill University, Dissemination and Training, May 14, 2024.
Development of POCD Technologies in Low-Resource Settings Aggrey Semeere, MBChB, M.med, MAS, Infectious Disease Institute, Clinical Site Lead, Uganda, May 14, 2024.
Practical Considerations for Developing Sustainable Diagnostics in LMICs Leonard Peruski, PhD, Wadsworth Center, NYS Health Department, Director, May 14, 2024.
Context-Specific Considerations for Developing POCD Tivani Mashamba-Thompson, PhD, University of Pretoria, External Advisory Board, May 14, 2024.
Setting the Stage: Path to Market Lara Vojnov, PhD, Chief Scientist, The Global Health Impact Group, May 14, 2024.
Using Pan-Pathogen Genomics Tools to Provide the Data Needed to Produce Fieldable Diagnostics J. Kenneth Wickiser, PhD, Columbia University – Global Alliance for Preventing Pandemics, Administrative Director, May 14, 2024.